| Un nuevo coronavirus, una nueva enfermedad: COVID-19 CG Quiroz Carrillo, A Pareja Cruz, E Valencia Ayala, ... Horizonte Médico (Lima) 20 (2), 2020 | 151 | 2020 |
| Pruebas diagnósticas para la COVID-19: la importancia del antes y el después P Aguilar Ramírez, Y Enriquez Valencia, C Quiroz Carrillo, ... Horizonte Médico (Lima) 20 (2), 2020 | 145 | 2020 |
| Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes SL Colombo, M Palacios-Callender, N Frakich, J De Leon, CA Schmitt, ... Proceedings of the National Academy of Sciences 107 (44), 18868-18873, 2010 | 140 | 2010 |
| Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity L Roque-Navarro, K Chakrabandhu, J de Leon, S Rodríguez, C Toledo, ... Molecular cancer therapeutics 7 (7), 2033-2041, 2008 | 101 | 2008 |
| Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody R Alonso, V Huerta, J de Leon, P Piedra, Y Puchades, O Guirola, ... Hybridoma 27 (4), 291-301, 2008 | 96 | 2008 |
| Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells J Leòn, A Fernandez, C Mesa, M Clavel, LE Fernandez Cancer Immunology, Immunotherapy 55, 443-450, 2006 | 84 | 2006 |
| Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation C Mesa, J De León, K Rigley, LE Fernández Vaccine 22 (23-24), 3045-3052, 2004 | 78 | 2004 |
| Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+ CD25− effector and naturally occurring CD4+ CD25+ regulatory T cells function J de Leon, A Fernández, M Clavell, M Labrada, Y Bebelagua, C Mesa, ... International Immunology 20 (4), 591-600, 2008 | 62 | 2008 |
| A view on EGFR-targeted therapies from the oncogene-addiction perspective R Perez, T Crombet, J Leon, E Moreno Frontiers in pharmacology 4, 53, 2013 | 53 | 2013 |
| Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles V Durand, J MacKenzie, J de Leon, C Mesa, V Quesniaux, M Montoya, ... Vaccine 27 (13), 1912-1922, 2009 | 51 | 2009 |
| Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens C Mesa, J de León, LE Fernández Vaccine 24 (14), 2692-2699, 2006 | 51 | 2006 |
| Gangliosides as immunomodulators M Potapenko, GV Shurin, J de León Immune-Mediated Diseases: From Theory to Therapy, 195-203, 2007 | 48 | 2007 |
| Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy M Labrada, M Clavell, Y Bebelagua, J León, DF Alonso, MR Gabri, ... Expert opinion on biological therapy 10 (2), 153-162, 2010 | 45 | 2010 |
| Inmunología del cáncer II: bases moleculares y celulares de la carcinogénesis J León, A Pareja Horizonte Médico (Lima) 19 (2), 84-92, 2019 | 28 | 2019 |
| Inmunología del cáncer I: bases moleculares y celulares de la respuesta inmune antitumoral J de León, A Pareja Horizonte Médico (Lima) 18 (3), 80-89, 2018 | 27 | 2018 |
| The potential use of tree-rings to reconstruct streamflow and estuarine salinity in the Valdivian Rainforest eco-region, Chile A Lara, R Urrutia, R Villalba, BH Luckman, D Soto, JC Aravena, ... Dendrochronologia 22 (3), 155-161, 2005 | 26 | 2005 |
| SARS-CoV-2 y sistema inmune: una batalla de titanes J de León Delgado, A Pareja Cruz, P Aguilar Ramirez, ... Horizonte Médico (Lima) 20 (2), 2020 | 20 | 2020 |
| Inmunoterapia en cáncer: de los inicios al premio Nobel L Vasquez, D Castro, J León, B Beltrán Revista Peruana de Medicina Experimental y Salud Pública 37, 115-121, 2020 | 19 | 2020 |
| Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg) A Macias, S Arce, J Leon, G Mustelier, G Bombino, A Domarco, R Perez, ... Hybridoma 18 (3), 263-272, 1999 | 19 | 1999 |
| Oncogenic transformation tunes the cross-talk between mesenchymal stem cells and T lymphocytes N Sánchez, A Miranda, JM Funes, G Hevia, R Pérez, J de León Cellular immunology 289 (1-2), 174-184, 2014 | 17 | 2014 |
